218 related articles for article (PubMed ID: 38440784)
1. Safe long-term therapy of Cushing's syndrome over 37 years with mitotane.
Seibold J; Hönemann M; Tönjes A; Sandner B
Front Endocrinol (Lausanne); 2024; 15():1294415. PubMed ID: 38440784
[TBL] [Abstract][Full Text] [Related]
2. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
3. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
Knappe G; Gerl H; Ventz M; Rohde W
Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
[TBL] [Abstract][Full Text] [Related]
4. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
5. Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center.
Baudry C; Coste J; Bou Khalil R; Silvera S; Guignat L; Guibourdenche J; Abbas H; Legmann P; Bertagna X; Bertherat J
Eur J Endocrinol; 2012 Oct; 167(4):473-81. PubMed ID: 22815335
[TBL] [Abstract][Full Text] [Related]
6. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
Braun LT; Reincke M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
[TBL] [Abstract][Full Text] [Related]
7. Mitotane and Carney Complex: ten years follow-up of a low-dose mitotane regimen inducing a sustained correction of hypercortisolism.
Campo MR; Lamacchia O; Farese A; Conserva A; Picca G; Grilli G; Cignarelli M
Hormones (Athens); 2015; 14(2):300-4. PubMed ID: 25402388
[TBL] [Abstract][Full Text] [Related]
8. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Viecceli C; Mattos ACV; Costa MCB; de Melo RB; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2022; 13():1017331. PubMed ID: 36277689
[TBL] [Abstract][Full Text] [Related]
10. Sustained remission of Cushing's disease with mitotane and pituitary irradiation.
Schteingart DE; Tsao HS; Taylor CI; McKenzie A; Victoria R; Therrien BA
Ann Intern Med; 1980 May; 92(5):613-9. PubMed ID: 6247946
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
12. Medical management of Cushing's disease: When and how?
Castinetti F
J Neuroendocrinol; 2022 Aug; 34(8):e13120. PubMed ID: 35348261
[TBL] [Abstract][Full Text] [Related]
13. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.
Zhao Y; Liang W; Cai F; Wu Q; Wang Y
Front Endocrinol (Lausanne); 2020; 11():608886. PubMed ID: 33391186
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.
Broersen LHA; Jha M; Biermasz NR; Pereira AM; Dekkers OM
Pituitary; 2018 Dec; 21(6):631-641. PubMed ID: 29855779
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
[TBL] [Abstract][Full Text] [Related]
17. Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.
Braun LT; Rubinstein G; Zopp S; Vogel F; Schmid-Tannwald C; Escudero MP; Honegger J; Ladurner R; Reincke M
Endocrine; 2020 Nov; 70(2):218-231. PubMed ID: 32743767
[TBL] [Abstract][Full Text] [Related]
18. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease.
Salenave S; Bernard V; Do Cao C; Guignat L; Bachelot A; Leboulleux S; Droumaguet C; Bry-Gauillard H; Pierre P; Crinière L; Santulli P; Touraine P; Chanson P; Schlumberger M; Maiter D; Baudin E; Young J
Eur J Endocrinol; 2015 Feb; 172(2):141-9. PubMed ID: 25411236
[TBL] [Abstract][Full Text] [Related]
19. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
20. [Management of hypercortisolism].
Rosales C; Fierrard H; Bertagna X; Raffin-Sanson ML
Rev Med Interne; 2008 Apr; 29(4):337-46. PubMed ID: 18226430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
